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Surveillance of antenatal influenza
vaccination: validity of current systems and
recommendations for improvement
Annette K. Regan1,2*, Donna B. Mak2, Hannah C. Moore3, Lauren Tracey2, Richard Saker4, Catherine Jones5
and Paul V. Effler1,2
Abstract
Background: Although influenza vaccination is recommended during pregnancy as standard of care, limited
surveillance data are available for monitoring uptake. Our aim was to evaluate the validity of existing surveillance in
Western Australia for measuring antenatal influenza immunisations.
Methods: The self-reported vaccination status of 563 women who delivered between April and October 2013 was
compared against three passive data collection sources: a state-wide antenatal influenza vaccination database
maintained by the Department of Health, a public maternity hospital database, and a private health service
database. Sensitivity, specificity, and positive and negative predictive values were calculated for each system using
self-report as the “gold standard.”
Results: The state-wide antenatal vaccination database detected 45.7 % (95 % CI: 40.1–51.4 %) of influenza
vaccinations, the public maternity hospital database detected 66.7 % (95 % CI: 55.1–76.9 %), and the private health
service database detected 29.1 % (95 % CI: 20.5–39.4 %). Specificity exceeded 90 % and positive predictive values
exceeded 80 % for each system. Sensitivity was lowest for women whose antenatal care was provided by a private
obstetrician.
Conclusions: Existing resources for surveillance of antenatal influenza vaccinations detect 29–67 % of vaccinations.
Considering the importance of influenza immunisation as a public health intervention, particularly in pregnant
women, improvements to routine monitoring of influenza vaccination is warranted.
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Background
To minimise the incidence of influenza infection in
pregnant women and infants aged less than 6 months,
the World Health Organization has recommended preg-
nant women be given the highest priority in seasonal in-
fluenza vaccination programs [1]. Due to the health
benefits to both mother and infant, influenza vaccination
has been recommended in Australia since 2009 [2]. Des-
pite strong recommendations promoting vaccination,
there is currently no comprehensive, population-based
surveillance system for antenatal influenza vaccination
nationally or in any Australian jurisdiction. Similar to
surveillance systems in the United States [3] and other
countries, estimates of influenza vaccine uptake in
Australia typically rely on self-reported data collected by
telephone survey. However, these surveys are not con-
ducted routinely and often rely on a small sample of
pregnant women. The most recent national estimate of
antenatal influenza vaccine uptake in Australia (12.7 %)
is based on results from a computer-assisted telephone
survey conducted in 2009 of just over 10,000 Australian
adults, 182 of whom were pregnant [4]. More recent
publications have reported uptake within a single juris-
diction or health service, and are not based on routinely
collected surveillance data [5–7].
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In the absence of a surveillance system for monitoring
antenatal vaccinations, WA Health has conducted an an-
nual survey of pregnant women who delivered during in-
fluenza season to estimate the proportion of women
who were vaccinated since 2012 [5]. While these surveys
have been useful in tracking vaccine uptake in pregnant
women and have demonstrated improvement from 10 %
in 2009 to 36 % in 2013 [7], implementing annual sur-
veys is resource-intensive and more efficient vaccine sur-
veillance methods may be available for this population.
Other potential data sources for monitoring influenza
vaccine uptake during pregnancy are summarised in
Table 1. In 2012, WA Health established the Western
Australian Influenza Vaccination Database (WAAIVD), a
state-wide database of government-funded antenatal in-
fluenza vaccinations reported to WA Health, as provided
by vaccination providers. Antenatal clinics, general prac-
titioners, and hospitals submit reports which include the
full name, date of birth, trimester of pregnancy, batch
number and brand of influenza vaccine administered. Re-
ports are generally submitted 1–2 days post-vaccination.
Between March 2012 and September 2014, 11,427 doses
of trivalent influenza vaccine were reported to WAAIVD.
In addition to this database, some public and private ma-
ternity hospitals maintain electronic databases into which
influenza vaccination status is entered after delivery and
before hospital discharge. The accuracy and completeness
of antenatal influenza vaccination status recorded in these
systems is currently unknown.
This study investigates the sensitivity, specificity and
positive and negative predictive values of antenatal influ-
enza vaccination status as recorded in the WAAIVD and
maternity hospital databases using self-reported vacci-
nated status from an annual survey as the “gold standard.”
Methods
Western Australia has a population of 2.5 million
people, representing 11 % of the total Australian popula-
tion [8]. Approximately 30,000 babies are delivered each
year in Western Australia. Hospital A is a large public
antenatal hospital in the Perth metropolitan area which
provides maternity care for 10 % of the metropolitan
population as well as high risk pregnancies across the
state. Health service B is a private health service located
in the north metropolitan area, which manages three
hospitals providing private maternity care for 20 % of
the metropolitan area.
In November and December 2013, 831 women who
were pregnant during the 2013 influenza vaccination
season and had given birth to a live baby between 07
April 2013 and 06 October 2013 were randomly selected
from Western Australia’s statutory Midwives Notifica-
tions System. The Western Australia Department of
Health conducted a 10-min computer-assisted telephone
interview with selected women, which asked whether
the woman had been vaccinated during her last preg-
nancy and reasons why or why she was not vaccinated
[7]. Vaccinated women were asked for permission to ver-
ify their self-reported vaccination status with their im-
munisation provider; 563 women provided details for
verification of their vaccination status with their immun-
isation provider: 211 delivered in health service B, 201
delivered in hospital A, and 151 delivered outside these
services (Fig. 1). Because the WAAIVD is a state-wide
database, the WAAIVD was screened for the vaccination
status of all 563 women who provided details, based on
full name and date of birth. Hospital A and health ser-
vice B were provided the names and dates of birth of
women who delivered within their respective health sys-
tem and were asked to screen their electronic medical
databases to confirm the women’s vaccination details.
This project was reviewed and approved by the Western
Australia Department of Health Human Research Ethics
Committee.
We calculated the sensitivity, specificity, positive pre-
dictive values (PPVs), and negative predictive values
(NPVs) for the WAAIVD and the electronic databases of
participating maternity hospitals. A number of studies
have shown that self-reported vaccination status is an
accurate measure of vaccination status [9–11]. As a re-
sult, we decided to use self-reported antenatal influenza
vaccination status as the “gold standard.” We calculated
95 % confidence intervals (CIs) using Wilson Score
intervals.
Table 1 Sources of antenatal influenza vaccination information evaluated
Source of influenza vaccination information
Western Australian Antenatal Influenza Vaccination Database Health service B database Hospital A database
Population covered All pregnant women within Western Australia Women who deliver in a
hospital within health service B
Women who deliver at
hospital A
Data collected Full name, date of birth, vaccination provider, date of vaccination,
brand and batch number of vaccine, and trimester of vaccination.
Vaccination status (yes/no) Vaccination status
(yes/no)
Time data collected and
entered into database
At time of vaccination After delivery and before
hospital discharge
After delivery and before
hospital discharge
Person responsible for
data collection and entry
Immunisation provider Health professional attending
birth
Health professional
attending birth
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Information on the woman’s age, antenatal care pro-
vider, chronic medical conditions, and postcode were
available based on survey responses. The woman’s post-
code was used to determine socioeconomic status, based
on calculated socioeconomic indexes for areas (SEIFA)
score, which is an indicator for socioeconomic condi-
tions by postcode. SEIFA is comprised of several indices,
the main index being the index of relative disadvantage
which is derived from low income, low educational at-
tainment, high unemployment and jobs in unskilled oc-
cupations [12]. Scores range from 700–1200. Estimates
were stratified by quintile based on the distribution of
scores in the state, with the lowest quintile indicating
the woman was in the most disadvantaged socioeco-
nomic group and the highest quintile indicating the
woman was in the least disadvantaged socioeconomic
group. Sensitivity and specificity were further stratified
by subgroups of women for the WAAIVD, as there was
sufficient sample size. Stratified sensitivity and specificity
values were compared using z-tests at α = .05.
We also calculated the proportion of vaccinations
which were recorded based on where the vaccine was
administered and the trimester of pregnancy when the
vaccine was administered. These proportions were com-
pared across vaccination records using Pearson chi-
square tests (α = .05).
Results
The demographic characteristics of participating women
are shown in Table 2. More than half of women were
30–39 years of age (57.4 %), were in the highest two
socioeconomic quintiles (58.8 %), and had an under-
graduate university degree or Training and Further Edu-
cation (TAFE) qualification (52.2 %); 15.8 % had a
chronic medical condition. Two in five women (44.1 %)
received their antenatal care at a public antenatal hos-
pital clinic; 37.3 % received care from a private obstetri-
cian, 17.1 % from a general practitioner, and 1.4 % from
another antenatal care provider.
A total of 37.9 % of women reported they had been
vaccinated against influenza during their most recent
pregnancy; 80.6 % of these could be verified with the im-
munisation provider. The majority of vaccinations were
administered by a general practitioner (59.6 %); 20.3 %
were administered by a public hospital antenatal clinic,
and 16.8 % were administered by another immunisation
provider, e.g. private hospital, community health clinic,
and workplace immunisation clinic; 3.2 % of women did
not specify who provided the vaccine. Most women re-
ported being vaccinated in either their second (56.5 %)
or third (31.7 %) trimester.
Western Australia Antenatal Influenza Vaccination Database
A total of 45.7 % self-reported vaccinations were identi-
fied in the WAAIVD. The specificity and PPV of the
WAAIVD was high (99.6 and 99.3 %, respectively).
Table 3 displays the accuracy measures of WAAIVD by
maternal age, SEIFA score, pre-existing medical condi-
tions and antenatal care provider. Sensitivity did not sig-
nificantly differ among women of varying ages, by
socioeconomic status, or by the presence of existing
clinical conditions. Sensitivity was significantly lower for
Fig. 1 Assessment of antenatal influenza vaccination surveillance, Western Australia 2013. WAAIVD, Western Australia Antenatal Influenza Vaccination
Database HSB, Health service B
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women who received the majority of their antenatal care
from a private obstetrician (33.6 % [95 % CI 26.2–41.8 %])
compared to women who received their care from a gen-
eral practitioner (52.6 % [95 % CI 39.9–65.0 %]) or public
hospital clinic (56.4 % [95 % CI 47.4–65.1 %], p < .01). A
total of 84.4 % (95 % CI 73.6–91.3 %) of vaccinations ad-
ministered at hospital A (a public maternity hospital) were
captured by the WAAIVD; whereas, only 42.5 % (95 % CI
35.7–49.7 %) of vaccinations administered by a general
practitioner and 13.2 % (95 % CI 6.5–24.8 %) administered
by another immunisation provider were captured by the
WAAIVD (p < .01) (data not shown). Significantly fewer
vaccinations were recorded in the WAAIVD when they
were administered in the first trimester (29.7 % [95 % CI
17.5–45.8 %]) than those administered in the third
trimester (61.0 % [95 % CI 51.2–70.0 %]) (p < .01) (data
not shown).
Maternity hospital databases
After examining the electronic maternity hospital data-
bases of hospital A and health service B, 47.0 % vaccina-
tions were identified (Fig. 1). The sensitivity of hospital
A’s system was significantly higher compared to that of
health service B (66.7 and 29.1 %, respectively, p < .01).
The specificity exceeded 90 % for each of the maternal
hospital databases. However, specificity of hospital A’s
maternity database was significantly lower (90.2 % [95 %
CI 83.7–94.3 %]) compared to that of the WAAIVD
(99.6 % [95 % CI 97.8–99.9 %], p < .05). The NPV of
health service B’s database was significantly lower com-
pared to NPV of hospital A’s database (66.7 and 81.0 %,
respectively; p < .05). The majority of vaccinations ad-
ministered at hospital A were recorded in a maternity
hospital database (80.4 % [95 % CI 67.5–89.0 %]);
whereas, 30.4 % (95 % CI 21.3–41.2 %) of vaccinations
administered by a general practitioner were recorded,
and 29.0 % (95 % CI 16.1–46.6 %) of vaccinations ad-
ministered by some other immunisation provider were
recorded (p < .01) (data not shown). No differences were
observed by trimester of vaccination.
Discussion
To our knowledge, this is the first formal evaluation of
data sources for estimating antenatal influenza vaccina-
tions using self-report as the “gold standard.” We found
that systems which rely on provider-reported vaccination
events or electronic medical records poorly capture in-
fluenza vaccinations administered to pregnant women,
and the validity of these systems varies widely. A state-
wide antenatal influenza vaccination database which re-
lies on passive reporting from immunisation providers
accurately recorded 46 % of influenza vaccinations ad-
ministered to pregnant women. Electronic medical re-
cords within a public maternity hospital recorded 67 %
of antenatal vaccinations, and public health service re-
cords recorded 29 %. These results indicate there is sig-
nificant under-reporting of vaccinations administered to
pregnant women in all systems.
The low sensitivity and negative predictive values iden-
tified in our study are perhaps not surprising, consider-
ing these systems rely on passive reporting from either
immunisation providers or hospital staff. Although sur-
veillance systems which rely on passive reporting have
methodological advantages, such as low cost and relatively
simple implementation, they often have low sensitivity
and may not be representative. In the case of maternal
vaccinations, it is apparent that immunisations are not
comprehensively reported and entered, as demonstrated
by our study. Previous research has demonstrated that
Table 2 Demographic characteristics of study participants
(n = 563), Western Australia 2013
Number of women (%)
Maternal age (in years)
18–29 210 (37.3 %)
30–39 323 (57.4 %)
40–45 30 (5.3 %)
Residence
Metropolitan 509 (90.4 %)
Rural/Remote 54 (9.6 %)
Socioeconomic status (SEIFA score)a
Quintile 1 (Most disadvantaged) 13 (2.4 %)
Quintile 2 63 (11.5 %)
Quintile 3 150 (27.3 %)
Quintile 4 194 (35.3 %)
Quintile 5 (Least disadvantaged) 129 (23.5 %)
Highest level of education completedb
≤High school graduate 175 (31.3 %)
Undergraduate/TAFE degree 292 (52.2 %)
Postgraduate degree 92 (16.5 %)
Existing Medical Conditions
No chronic medical conditionc 474 (84.2 %)
Has ≥1 chronic medical condition 89 (15.8 %)
Antenatal care providerd
Public antenatal hospital clinic 247 (44.1 %)
General practitioner 96 (17.1 %)
Private obstetrician 209 (37.3 %)
Other providere 8 (1.4 %)
aSEIFA, Socioeconomic indexes for areas; n = 549; 14 women had unknown
SEIFA scores
bn = 559; 4 women had unknown educational attainment
cChronic medical conditions included asthma, chronic heart disease, diabetes,
and chronic lung disorders
dn = 560; 3 women did not provide details on their antenatal care provide
eOther antenatal care providers included independent midwives, community
midwifery programs, and the Royal Australian Flying Doctors Services
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Table 3 Validity of the Western Australia Antenatal Influenza Vaccination Database (WAAIVD) for capturing antenatal vaccinations (n = 563), by patient characteristics
Subgroup Recorded Vaccinationsa True Vaccinationsb Sensitivity PPVc Specificity NPVd
n N % (95 % CI) % (95 % CI) % (95 % CI) % (95 % CI)
Total 145 144 45.7 (40.1–51.4) 99.3 (96.2–99.9) 99.6 (97.8–99.9) 59.1 (54.3–63.7)
Maternal age (years)
18–29 49 107 44.9 (35.8–54.3) 97.9 (89.3–99.6) 99.0 (94.7–99.8) 63.3 (55.7–70.4)
30–39 85 187 45.5 (38.5–52.6) 100 (95.7–100) 100 (97.3–100) 57.1 (50.8–63.3)
40–45 11 21 52.4 (32.4–71.7) 100 (74.1–100) 100 (70.1–100) 47.4 (27.3–68.3)
Socioeconomic status (SEIFA score)e
Quintile 1 (Most disadvantaged) 3 12 25.0 (5.5–57.2) 100 (43.9–100) 100 (56.6–100) 35.7 (16.3–61.2)
Quintile 2 17 32 53.1 (34.7–70.9) 100 (81.6–100) 100 (83.9–100) 57.1 (40.9–72.0)
Quintile 3 32 69 44.9 (32.9–57.4) 96.9 (84.3–99.4) 96.9 (83.8–99.4) 44.1 (32.9–55.9)
Quintile 4 31 56 55.4 (42.4–67.6) 100 (88.8–100) 100 (93.0–100) 67.1 (55.9–76.6)
Quintile 5 (Least disadvantaged) 56 138 40.6 (32.7–48.9) 100 (93.6–100) 100 (97.1–100) 61.1 (54.4–67.5)
Existing medical conditions
Has ≥1 chronic medical condition 22 46 47.8 (34.1–61.9) 100 (85.1–100) 100 (91.8–100) 64.2 (52.2–74.6)
No chronic medical condition 123 269 45.3 (39.5–51.3) 99.2 (95.5–99.9) 99.5 (97.3–99.9) 58.1 (52.9–63.2)
Antenatal (AN) care providerf
Public hospital AN clinic 67 117 56.4 (47.4–65.1) 98.5 (92.0–99.7) 99.2 (95.8–99.9) 71.7 (64.7–77.7)
General practice clinic 30 57 52.6 (39.9–65.0) 100 (88.6–100) 100 (91.0–100) 59.1 (47.0–70.1)
Private obstetrician 46 137 33.6 (26.2–41.8)§§ 100 (92.3–100) 100 (94.9–100) 44.2 (36.8–51.8)g
aRecorded vaccinations were defined as vaccination events identified in the state’s antenatal influenza vaccination database, based on provider-reported vaccination information
bTrue vaccinations were defined as vaccination events self-reported by the woman during telephone interview
cPPV, positive predictive value
dNPV, negative predictive value
eSEIFA, Socioeconomic indexes for areas
fAntenatal care provider was defined as the healthcare professional who provided the majority of antenatal care as self-reported at the time of telephone interview
gSignifiant at p < .05
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incentives can be used to improve the timeliness and ac-
curacy of recording vaccination events, and this may be
one method for improving the validity of these systems
[13, 14]. However, this introduces additional resource re-
quirements for sustaining this surveillance activity. Educa-
tion and targeted intervention may also improve
recording; for example, in our setting, only one-third of
vaccinations administered by a general practitioner were
recorded in the state vaccination database. Targeted edu-
cation could help improve provider reporting from these
sites.
Vaccinations administered outside of traditional pro-
viders, such as places of employment, were also infre-
quently recorded in these systems, likely because these
providers are unlikely to report vaccination events to the
state government and are less often included in hospital
records, as observed by our study. Previous investiga-
tions have shown that approximately 30 % of working-
age adults receive influenza vaccines in non-traditional
healthcare settings [15], and nine percent of vaccinated
women in our study reported having been vaccinated at
their workplace. Considering 13 % of immunisations
provided outside of general practice or public hospital
clinics were recorded by the WAAIVD and 29 % were
recorded in the maternity hospital database, this is likely
a large factor in the under-reporting of vaccinations to
these systems and an area for improvement.
In the absence of a comprehensive system for moni-
toring adult vaccinations, such as an adult vaccination
register, influenza vaccinations are difficult to routinely
monitor in all adults. However, unique to antenatal vac-
cinations, there are two logical time points available for
recording influenza vaccinations during pregnancy: once
at vaccine administration, as the WAAIVD is structured,
and again at delivery, as recorded by hospital databases.
Data collection at the time of delivery can be logistically
convenient as there are statutory requirements for the
collection of information related to the pregnancy and
birth [16]. Under the Health Act 1911, midwives are re-
quired to notify the Department of Health of the out-
comes of all birth events within 28 h of birth by
completing a Notification of Case Attended form [16].
Data collected in these forms are used to establish the
Midwives Notification System, a state-based perinatal
data collection [17]. The inclusion of influenza vaccin-
ation status in state or national perinatal data collections
would establish an annual, electronic source of estimat-
ing influenza vaccine uptake in pregnant women. Other
countries such as Canada choose to monitor influenza
vaccination in this way. For example, the Nova Scotia
Atlee Perinatal Database, a population perinatal database
collects data on maternal health, details on the delivery,
and information related to influenza vaccination [18].
Data are collected after hospital discharge and are based
on standardised clinical forms and hospital records.
These databases have proven useful for evaluating up-
take and the effectiveness of maternal immunisation
programs and could be used for similar purposes in
Australia.
Globally, there are three types of systems which have
been used to estimate influenza vaccine uptake during
pregnancy: 1) population surveys; 2) healthcare utilisa-
tion, insurance claims, and pharmaceutical dispensary
data; and 3) vaccination registries. Population surveys
are a valid and reliable method for estimating uptake
[5–7] and have been previously used for surveillance of
maternal influenza immunisations in Australia [4]. How-
ever, they are time-consuming, resource intensive, and
can be difficult to implement annually. Health service
utilisation and health insurance claims databases have
also been used for surveillance of maternal influenza im-
munisation. The UK General Practice Research Data-
base, a primary care database containing de-identified
health records from 8.4 % of the UK population, has
been used to determine the proportion of women immu-
nised against influenza [19, 20]. In the United States,
patient-specific insurance claims data, such as Kaiser
Permanente health plan membership data [21, 22] and
LifeLinkTM Health Plan Claims Database [23] have been
used to evaluate uptake of influenza vaccine during
pregnancy. In France, a database of prescription use in
the general population has been used to evaluate risks
associated with drugs administered during pregnancy
[24, 25]. While these databases tend to draw from a
large population of unique members and have produced
estimates similar to those of population surveys [18, 20],
such databases are not necessarily designed to provide
accurate vaccination uptake estimates. National data-
bases or registries, such as the national database in
Denmark which was established during the H1N1 pan-
demic to monitor H1N1 vaccination [26], are an ideal
source of vaccination uptake data. However, the Denmark
registry was restricted to pandemic vaccinations, and
would need to be maintained annually for it to be useful
in monitoring seasonal influenza vaccine uptake in preg-
nant women.
Electronic vaccination registries of the whole popula-
tion, such as those of Denmark and a number of other
countries in Europe [27, 28], could be used to collect
seasonal influenza vaccination information needed to
evaluate vaccination programs, in pregnant women and
other target groups. Australia’s electronic immunisation
registry is currently restricted to children under the age
of seven years, and the case for a whole-of-life immun-
isation registry in Australia has been argued in the past
[29, 30]. Expansion of this registry to adults would allow
for monitoring of influenza vaccination during preg-
nancy as well as other target groups. Previous research
Regan et al. BMC Public Health  (2015) 15:1155 Page 6 of 8
has shown that electronic vaccination registries estimate
vaccination status similar to self-reported vaccination
status for women and high risk groups [31, 32], and
electronic information is likely the most efficient source
of routine vaccination information. Recent establishment
of antenatal pertussis vaccination programs in the
United Kingdom and the United States of America, and
their imminent introduction in Australian jurisdictions
underscore the importance of national surveillance sys-
tems for adult, including antenatal, vaccination uptake.
There are several limitations to consider when inter-
preting our data. First, we used self-reported vaccination
status as the “gold standard” in this evaluation. While
self-report has historically been proven to be a good
measure of vaccination status, it could be argued that
this is an imperfect measure. In our study, the majority
of self-reported vaccinations could be verified by the im-
munisation provider (80.6 %); however, influenza vaccines
administered in the workplace or by non-traditional pro-
viders could not be verified. Published literature support
the validity of self-reported vaccination status in adults
and indicate that false negative self-reports are extremely
rare. The sensitivity of self-report has previously been
shown to range from 90–100 % [9–11], and self-reported
vaccination status is commonly used to estimate influenza
vaccine coverage [33, 34]. However, given 20 % of self-
reported records could not be verified, it is possible that
some self-reported vaccinations were inaccurately classi-
fied as ‘true.’ Second, hospital A routinely offers influenza
vaccination to its patients and reports these to WA
Health. Hospital A is responsible for the majority of deliv-
eries in public hospitals in Western Australia. It is likely
that a large proportion of women who reported a public
hospital clinic as their antenatal care provider were immu-
nised at hospital A and were more likely to be recorded.
Third, Hospital A and health service B provide maternity
services within the metropolitan area of the state, and so
the sample of women in this evaluation may not be repre-
sentative of pregnant women across Western Australia. Fi-
nally, it is possible that a name and date of birth search in
both databases was insufficient to identify women, which
may lead to some discrepancies in the data.
Conclusions
Monitoring influenza vaccine coverage is an integral
component of national and state-based evaluation of im-
munisation programs, particularly for influenza, which is
administered annually to a range of target groups [29,
33, 35]. Considering influenza vaccination is an import-
ant intervention for preventing disease in pregnant
women and is a component of standard care for ante-
natal patients, surveillance of antenatal influenza vaccin-
ation could be improved. In addition to identifying
contributing factors to the poor sensitivity of the systems
evaluated in this study, additional systems for recording
antenatal influenza vaccinations, such as recording vac-
cination status in perinatal data collections, are available
which could be used to monitor this public health inter-
vention. The gaps identified in this evaluation likely
apply to other populations where monitoring vaccine
uptake annually can be difficult. Exploration of alternative
vaccination registers which include both children and
adults, and record indication/s for vaccination, such as
pregnancy and immunosuppression could potentially re-
place the fragmented immunisation registers currently
available for specific age groups or vaccines. Such infor-
mation is critical for providing data for monitoring cover-
age and evaluating disease prevention programs [29, 35].
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